Interim analysis shows merck's antiviral molnupiravir reduces risk of hospitalization or death by 50%

PTVPhilippines 2021-10-06

Views 3

Interim analysis shows merck's antiviral molnupiravir reduces risk of hospitalization or death by 50%

Share This Video


Download

  
Report form
RELATED VIDEOS